We build models that estimate the cost from incorporating a new therapy into a health plan or system. These models are population-based, meaning that they incorporate incidence and prevalence rates for the population of interest. They generally compare a new therapy to the current standard of care, which could be one therapy or many. The models typically account for costs of therapy, cost offsets from reduced needs for other therapies, and cost savings from prevented events related to the condition being treated. Each model is unique, but most share these common components.
While budget impact models are not usually published, we have published one that is listed below: